Table 2.
Explanatory Variables | Nagelkerke Pseudo R2 | χ2 (df) p-Values |
B | Standard Error | Wald df = 1 | p | Odds Ratio | 95% CI |
---|---|---|---|---|---|---|---|---|
All patients vs. HC | 0.448 | 56.83 (6) | ||||||
AI⸧ (A11) | −1.113 | 0.308 | 14.24 | <0.001 | 0.31 | 0.17–0.57 | ||
MFG→FEF (A34) | 0.722 | 0.252 | 8.23 | 0.004 | 2.05 | 1.26–3.37 | ||
HPC→FEF (A84) | 0.684 | 0.231 | 8.77 | 0.003 | 1.98 | 1.26–3.12 | ||
AMY→SPL (A76) | −0.780 | 0.263 | 8.81 | 0.003 | 0.46 | 0.27–0.77 | ||
AI→AMY (A17) | 1.261 | 0.282 | 20.02 | <0.001 | 3.53 | 2.03–6.13 | ||
MFG→AMY (A37) | 0.827 | 0.279 | 8.78 | 0.003 | 2.29 | 1.32–3.95 | ||
MOOD vs. HC | 0.487 | 45.69 (5) <0.001 | ||||||
AI (A11) | −1.348 | 0.401 | 11.27 | 0.001 | 0.26 | 0.12–0.57 | ||
MFG→FEF (A34) | 1.105 | 0.350 | 9.97 | 0.002 | 3.02 | 1.52–6.00 | ||
HPC→FEF (A84) | 0.950 | 0.295 | 10.40 | 0.001 | 2.59 | 1.45–4.61 | ||
AI→AMY (A17) | 1.380 | 0.381 | 13.14 | <0.001 | 3.97 | 1.89–8.38 | ||
MFG→AMY (A37) | 1.180 | 0.371 | 10.11 | 0.001 | 3.26 | 1.57–6.74 | ||
SCZ vs. HC | 0.316 | 12.16 (2) 0.002 | ||||||
AI→AMY (A17) | 0.802 | 0.382 | 4.41 | 0.036 | 2.23 | 1.06–4.71 | ||
AMY→SPL (A76) | −1.112 | 0.479 | 5.40 | 0.020 | 0.03 | 0.13–0.84 |